Genvoya® (Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide) 150/150/200/10 mg for HIV-1 Treatment
USAMP#14821421SKU: 61958190101Genvoya®
License Required
Product Spotlight
Comprehensive treatment for HIV-1 infection in individuals 12 years and older (weighing at least 35 kg), suitable for patients new to antiretroviral therapy or as a regimen replacement for those virologically-suppressed.
Each bottle contains 30 green, capsule-shaped, film-coated tablets, debossed with “GS”, designed for once-daily oral administration.
Formulated to minimize the risk of treatment failure and resistance, ensuring effective long-term virus suppression.
Produced by Gilead Sciences Inc, Genvoya® combines four potent antiretroviral agents in a single tablet, simplifying treatment regimens.
